Who are Singular Genomics Systems's investors?

Singular Genomics Systems's investors include Deerfield Management, ARCH Venture Partners, Revelation Partners, Legend Capital, F-Prime Capital.

When was Singular Genomics Systems founded?

Singular Genomics Systems was founded in 2016.

Where is Singular Genomics Systems headquartered?

Singular Genomics Systems is headquartered in San Diego, California, United States.

What industry is Singular Genomics Systems in?

Singular Genomics Systems operates in Biotech, Healthcare.

How many employees does Singular Genomics Systems have?

Singular Genomics Systems has 51-200 employees.

Singular Genomics Systems

Acquired

Delivering the Future of Spatial Pathology

San Diego, United States · Founded 2016

Biotech

Healthcare

Headquarters: San Diego, California
Employees: 51–200
Founded: 2016

Business Model: B2B
Last Round: Convertible NoteFeb 2021
Rounds: 3

About

Singular Genomics is a life science technology company based in San Diego, California that developed the G4X Spatial Sequencing Platform for high-throughput in situ multiomics. The platform captures transcriptomics, proteomics, and fH&E imaging from the same FFPE tissue section at subcellular resolution, enabling large-scale, cost-effective spatial tissue profiling for precision diagnostics, translational research, and personalized medicine, while also functioning as a flexible next-generation sequencing platform.

Summary

Singular Genomics Systems is a Biotech company based in San Diego, United States, founded in 2016. Its most recent funding was a Convertible Note round in Feb 2021. Investors include Deerfield Management, ARCH Venture Partners and Revelation Partners.

X (Twitter)